Article
A double tyrosine phosphorylation of P68 RNA helicase confers resistance to TRAIL-induced apoptosis.
Oncogene - 6 Sept 2007
Yang L, Lin C, Sun S-Y, Zhao S, Liu Z-R
Abstract excerpt
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent with the capability of inducing apoptosis specifically in tumor cells. However, cancer cells of many cancer types developed TRAIL resistance, limiting the applications of TRAIL in cancer therapies. We show here that p68 acquires a double tyrosine phosphorylation at Y593 and Y595 in TRAIL-resistant T98G glioblastoma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
